131 related articles for article (PubMed ID: 17929935)
1. Latrunculin with a highly oxidized thiazolidinone ring: structure assignment and actin docking.
Ahmed SA; Odde S; Daga PR; Bowling JJ; Mesbah MK; Youssef DT; Khalifa SI; Doerksen RJ; Hamann MT
Org Lett; 2007 Nov; 9(23):4773-6. PubMed ID: 17929935
[TBL] [Abstract][Full Text] [Related]
2. Semisynthetic latrunculin B analogs: studies of actin docking support a proposed mechanism for latrunculin bioactivity.
Kudrimoti S; Ahmed SA; Daga PR; Wahba AE; Khalifa SI; Doerksen RJ; Hamann MT
Bioorg Med Chem; 2009 Nov; 17(21):7517-22. PubMed ID: 19800245
[TBL] [Abstract][Full Text] [Related]
3. Differential binding of latrunculins to G-actin: a molecular dynamics study.
Helal MA; Khalifa S; Ahmed S
J Chem Inf Model; 2013 Sep; 53(9):2369-75. PubMed ID: 23988111
[TBL] [Abstract][Full Text] [Related]
4. Semisynthetic latrunculin derivatives as inhibitors of metastatic breast cancer: biological evaluations, preliminary structure-activity relationship and molecular modeling studies.
Khanfar MA; Youssef DT; El Sayed KA
ChemMedChem; 2010 Feb; 5(2):274-85. PubMed ID: 20043312
[TBL] [Abstract][Full Text] [Related]
5. Molecular Dynamics Simulation Reveal the Mechanism of Resistance of Mutant Actins to Latrunculin A - Insight into Specific Modifications to Design Novel Drugs to Overcome Resistance.
Lalitha R; R PK; Mohammed MM
Curr Comput Aided Drug Des; 2016; 12(2):107-18. PubMed ID: 27484118
[TBL] [Abstract][Full Text] [Related]
6. Interrogating the bioactive pharmacophore of the latrunculin chemotype by investigating the metabolites of two taxonomically unrelated sponges.
Amagata T; Johnson TA; Cichewicz RH; Tenney K; Mooberry SL; Media J; Edelstein M; Valeriote FA; Crews P
J Med Chem; 2008 Nov; 51(22):7234-42. PubMed ID: 18942825
[TBL] [Abstract][Full Text] [Related]
7. Latrunculin alters the actin-monomer subunit interface to prevent polymerization.
Morton WM; Ayscough KR; McLaughlin PJ
Nat Cell Biol; 2000 Jun; 2(6):376-8. PubMed ID: 10854330
[No Abstract] [Full Text] [Related]
8. Latrunculin A and its C-17-O-carbamates inhibit prostate tumor cell invasion and HIF-1 activation in breast tumor cells.
Sayed KA; Khanfar MA; Shallal HM; Muralidharan A; Awate B; Youssef DT; Liu Y; Zhou YD; Nagle DG; Shah G
J Nat Prod; 2008 Mar; 71(3):396-402. PubMed ID: 18298079
[TBL] [Abstract][Full Text] [Related]
9. A new dimension to the biosynthetic products isolated from the sponge Negombata magnifica.
Vilozny B; Amagata T; Mooberry SL; Crews P
J Nat Prod; 2004 Jun; 67(6):1055-7. PubMed ID: 15217296
[TBL] [Abstract][Full Text] [Related]
10. Latrunculin analogues with improved biological profiles by "diverted total synthesis": preparation, evaluation, and computational analysis.
Fürstner A; Kirk D; Fenster MD; Aïssa C; De Souza D; Nevado C; Tuttle T; Thiel W; Müller O
Chemistry; 2007; 13(1):135-49. PubMed ID: 17091521
[TBL] [Abstract][Full Text] [Related]
11. 3D-QSAR studies of latrunculin-based actin polymerization inhibitors using CoMFA and CoMSIA approaches.
Khanfar MA; Youssef DT; El Sayed KA
Eur J Med Chem; 2010 Sep; 45(9):3662-8. PubMed ID: 20684858
[TBL] [Abstract][Full Text] [Related]
12. Total syntheses of the actin-binding macrolides latrunculin A, B, C, M, S and 16-epi-latrunculin B.
Fürstner A; De Souza D; Turet L; Fenster MD; Parra-Rapado L; Wirtz C; Mynott R; Lehmann CW
Chemistry; 2007; 13(1):115-34. PubMed ID: 17091520
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of interdomain motion in g-actin by the natural product latrunculin: a molecular dynamics study.
Rennebaum S; Caflisch A
Proteins; 2012 Aug; 80(8):1998-2008. PubMed ID: 22488806
[TBL] [Abstract][Full Text] [Related]
14. Diverted total synthesis: preparation of a focused library of latrunculin analogues and evaluation of their actin-binding properties.
Fürstner A; Kirk D; Fenster MD; Aïssa C; De Souza D; Müller O
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8103-8. PubMed ID: 15917332
[TBL] [Abstract][Full Text] [Related]
15. Latrunculin A Accelerates Actin Filament Depolymerization in Addition to Sequestering Actin Monomers.
Fujiwara I; Zweifel ME; Courtemanche N; Pollard TD
Curr Biol; 2018 Oct; 28(19):3183-3192.e2. PubMed ID: 30270183
[TBL] [Abstract][Full Text] [Related]
16. Molecular and protein characterization of two species of the latrunculin-producing sponge Negombata from the Red Sea.
Eid ES; Abo-Elmatty DM; Hanora A; Mesbah NM; Abou-El-Ela SH
J Pharm Biomed Anal; 2011 Dec; 56(5):911-5. PubMed ID: 21852057
[TBL] [Abstract][Full Text] [Related]
17. Structure-Activity Studies of Truncated Latrunculin Analogues with Antimalarial Activity.
Varghese S; Rahmani R; Drew DR; Beeson JG; Baum J; Smith BJ; Baell JB
ChemMedChem; 2021 Feb; 16(4):679-693. PubMed ID: 32929894
[TBL] [Abstract][Full Text] [Related]
18. Truncated Latrunculins as Actin Inhibitors Targeting Plasmodium falciparum Motility and Host Cell Invasion.
Johnson S; Rahmani R; Drew DR; Williams MJ; Wilkinson M; Tan YH; Huang JX; Tonkin CJ; Beeson JG; Baum J; Smith BJ; Baell JB
J Med Chem; 2016 Dec; 59(24):10994-11005. PubMed ID: 28002959
[TBL] [Abstract][Full Text] [Related]
19. Actin-latrunculin A structure and function. Differential modulation of actin-binding protein function by latrunculin A.
Yarmola EG; Somasundaram T; Boring TA; Spector I; Bubb MR
J Biol Chem; 2000 Sep; 275(36):28120-7. PubMed ID: 10859320
[TBL] [Abstract][Full Text] [Related]
20. Toward computing relative configurations: 16-epi-latrunculin B, a new stereoisomer of the actin polymerization inhibitor latrunculin B.
Hoye TR; Ayyad SE; Eklov BM; Hashish NE; Shier WT; El-Sayed KA; Hamann MT
J Am Chem Soc; 2002 Jun; 124(25):7405-10. PubMed ID: 12071749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
